Antiangiogenic cancer drug drives lymphangiogenic metastasis

    loading  Checking for direct PDF access through Ovid

Abstract

Tumor blood vessel–destroying cancer drug induces development of tumor lymphatics that contribute to treatment failure.

Related Topics

    loading  Loading Related Articles